Countries Australia
Telix Pharmaceuticals Completes Acquisition of RLS Radiopharmacies to Strengthen U.S. Radiopharmaceutical Footprint
Telix Pharmaceuticals Limited announces it has completed the acquisition of RLS (USA) Inc. (RLS; RLS Radiopharmacies), America's only Joint Commission-accr...
January 28, 2025 | News
Clarity Pharmaceuticals Secures Second FDA Fast Track Designation for 64Cu-SAR-bisPSMA in Prostate Cancer Imaging
Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation product...
January 27, 2025 | News
Pearl Partners with Australia’s Centaur to Advance Dental AI Across Asia Pacific and Middle East
Pearl, the global leader in dental AI solutions, announced a strategic partnership with Centaur, Australia’s leading dental practice management ...
January 22, 2025 | News
Junshi Biosciences Secures Australian Approval for Toripalimab, First Immuno-Oncology Treatment for Nasopharyngeal Carcinoma
Shanghai Junshi Biosciences Co., Ltd , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercializati...
January 21, 2025 | News
Telix Receives Regulatory Nod for PSMA PET Imaging in Prostate Cancer Across 19 European Nations
Telix Pharmaceuticals Limited announces that it has received a positive decision on the Marketing Authorization Application (MAA) for its prostate ca...
January 20, 2025 | News
HALEO Partners with Munich Re Australia to Transform Disability Management Through Sleep Care
HALEO, a leader in virtual care for sleep disorders, is proud to announce a partnership with Munich Re Australia aimed at enhancing disability management t...
January 17, 2025 | News
BioCina and NovaCina Merge to Establish Global Powerhouse in Biopharmaceutical and Small Molecule Manufacturing
Global Contract Development and Manufacturing Organizations (CDMOs) BioCina and NovaCina announced a strategic merger that will create a powerful brand in ...
January 14, 2025 | News
Telix Pharmaceuticals Acquires ImaginAb’s Biologics Platform and Therapeutics Pipeline to Advance Precision Radiopharmaceuticals
Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, "Telix" or "the Company") today announced the acquisition of a next-generation therapeutics pipeline ...
January 13, 2025 | News
Norgine Submits Marketing Authorisation Application to EMA for Eflornithine in High-Risk Neuroblastoma
Norgine announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk ne...
January 07, 2025 | News
Bayer Secures Key Resolution as Federal Court of Australia Ends Roundup™ Litigation
Federal Court of Australia discontinues the last pending case This follows significant win in first Roundup™ final judgment on non-Hodgkin l...
January 06, 2025 | News
Innovent Biologics and Roche Forge Strategic Alliance to Advance DLL3-Targeted ADC for Small Cell Lung Cancer
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...
January 02, 2025 | News
Radiopharm and Lantheus Join Forces to Advance Radiopharmaceutical Clinical Development in Australia
RAD to advance the clinical development of Lantheus innovative radiopharmaceuticals in Australia Initial collaboration will focus on a Phase 1 imaging t...
December 31, 2024 | News
Australia’s Telix Submits FDA Application for TLX250-CDx, a Breakthrough PET Imaging Agent for Kidney Cancer
Telix Pharmaceuticals Limited announces that it has submitted its Biologics License Application (BLA) to the United States (U.S.) Food and Drug Administrat...
December 30, 2024 | News
Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
In an exclusive interview with BioPharma APAC, Ed Deng, Co-founder and CEO of Health2Sync, delves into the transformative impact of their collabora...
December 24, 2024 | Interaction
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
